{"id":6372,"date":"2021-01-16T00:02:40","date_gmt":"2021-01-16T00:02:40","guid":{"rendered":"https:\/\/biggeesblog.cymru\/?page_id=6372"},"modified":"2022-03-10T20:53:33","modified_gmt":"2022-03-10T20:53:33","slug":"a-running-journal-of-written-correspondence-volume-2","status":"publish","type":"page","link":"https:\/\/biggeesblog.cymru\/index.php\/a-running-journal-of-written-correspondence-volume-2\/","title":{"rendered":"A Running Journal of Written Correspondence [Volume 2]"},"content":{"rendered":"

\"\"<\/h1>\n

To View VOLUME – 1 [Index Nos. 01 – 100]<\/span>\"\"<\/a>To View VOLUME – 3 [Index Nos. 201 – 300]<\/span>\"\"<\/a><\/h4>\n
\n

Below is Volume 2 of a journal tracking correspondence to various organisations and governments requesting information and clarification regarding this ongoing \u2018Covid-19\u2019 episode. Each volume contains 100 individual enquiries to officialdom – including letters and Freedom Of Information Requests.<\/p>\n

Replies (when received) are also published under the appropriate Index number issued. Please feel free to comment<\/a><\/span><\/span> on the contents of this page, or to request enquiries on your behalf.<\/p>\n

\"\"<\/h1>\n

Last Updated: 13th <\/sup><\/span>of December 2021<\/span><\/span><\/h1>\n

 <\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

\u00a0INDEX No.<\/span>
\n<\/strong><\/span><\/p>\n

\u00a0<\/em><\/span>Click on Index <\/em>Number below to go to content<\/em><\/span><\/span><\/p>\n<\/td>\n

CORRESPONDENCE\u00a0 \u00a0SUBJECT\/\u00a0 \u00a0TITLE<\/span><\/strong><\/span><\/p>\n

 <\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/tr>\n
200<\/a><\/strong><\/span><\/td>\nTo: Freedom of Information Team, <\/strong>Public Health Wales, <\/strong>2 Capital Quarter, <\/strong>Tyndall<\/strong><\/span> Street, <\/strong>Cardiff.<\/strong><\/span><\/p>\n

Subject: Diagnostic test – Covid 19 Delta Variant.<\/span>
\n<\/b><\/span><\/td>\n<\/tr>\n

199<\/a><\/strong><\/span><\/td>\nTo: Customer Contact Centre, Welsh Government, Cathays Park, Cardiff.<\/strong><\/span><\/p>\n

Subject: Funding of \u00a3200,000 provided by Welsh Government to Swansea University working in conjunction with Innoture<\/b><\/span><\/td>\n<\/tr>\n

198<\/a><\/strong><\/span><\/td>\nTo: Customer Contact Centre, Welsh Government, Cathays Park, Cardiff.<\/strong><\/span><\/p>\n

Subject: Request for voluntary Regulatory Impact Assessment [R I A]<\/b><\/span><\/td>\n<\/tr>\n

197<\/a><\/strong><\/span><\/td>\nTo: Freedom of Information Team, UK Health Security Agency [former PHE], Wellington House, 133-155 Waterloo Road, London.<\/strong><\/span><\/p>\n

Subject: RT-PCR testing at private laboratory suspended<\/b><\/span><\/td>\n<\/tr>\n

196<\/a><\/strong><\/span><\/td>\nTo: Customer Contact Centre, Welsh Government, Cathays Park, Cardiff.<\/strong><\/span><\/p>\n

Subject: Covid Status Check Schemes – Wales<\/b><\/span><\/td>\n<\/tr>\n

195<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Press Office,<\/strong> <\/span>UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London.<\/strong><\/span><\/p>\n

Subject: Clarification on role of U K Health Security Agency<\/b><\/span><\/td>\n<\/tr>\n

194<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Customer Contact Team, <\/strong>Drinking Water Inspectorate [D T I], <\/strong>Department for Environment Food and Rural Affairs [D E F R A], <\/strong>U K Government.<\/strong><\/span><\/p>\n

Subject: Use of Graphene Oxide in potable water filtration<\/b><\/span><\/td>\n<\/tr>\n

193<\/a><\/strong><\/span><\/td>\nTo: Customer Contact Centre, Welsh Government, Cathays Park, Cardiff.<\/strong><\/span><\/p>\n

S<\/b>ubject: Request for voluntary Regulatory Impact Assessment [RIA]<\/b>\u00a0<\/span><\/td>\n<\/tr>\n


\n192<\/a><\/strong><\/span><\/td>\n		To:\u00a0 Freedom of Information Team,,<\/strong>Department for Health and Social Care, <\/strong>39 Victoria Street, <\/strong>London.<\/strong><\/span><\/p>\n

Subject: Protocol for disclosing conflict of interest – Senior medical \/ scientific advisors to DHSC<\/b>
\n<\/span><\/td>\n<\/tr>\n

191<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Customer Service Team, <\/strong>Medicines and Healthcare Products Regulatory Agency [M H R A], <\/strong>10 South Colonnade, <\/strong>Canary Wharf, <\/strong>London.<\/strong><\/span><\/p>\n

Subject: Project Smart Safety Surveillance [Project 3-S]<\/b><\/span><\/td>\n<\/tr>\n

190<\/a><\/strong><\/span><\/td>\nTo: Dr Frank Atherton, <\/strong>Chief Medical Officer [Wales], <\/strong>Population Health Directorate, <\/strong>Cathays Park, Cardiff.<\/strong><\/span><\/p>\n

Subject: Influenza Vaccines for the 2021 \/ 22 season<\/b>\u00a0<\/span><\/td>\n<\/tr>\n

189<\/a><\/strong><\/span><\/td>\n\u00a0To:\u00a0 Freedom of Information Team, Hywel Dda University Health Board, Corporate Offices, Ystwyth Building, St David’s Park, Job’s Well Road, Carmarthen, Carmarthenshire. <\/strong><\/span><\/p>\n

Subject: Primary Care [Moderna Vaccine Covid 19 Immunisation Scheme] Directions 2021<\/b><\/span><\/td>\n<\/tr>\n

188<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Customer Contact Centre, <\/strong>Welsh Government, <\/strong>Cathays Park, <\/strong>Cardiff. <\/strong><\/span><\/p>\n

Subject: Covid Passport for events and nightclubs in Wales<\/b><\/span><\/td>\n<\/tr>\n

187<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, M H R A, 10 South Colonnade, London.<\/strong><\/span><\/p>\n

Subject: CoV Boost Study – Request for Information<\/b>
\n<\/span><\/td>\n<\/tr>\n

186<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Well Healthcare Services, <\/strong>Customer Care Team, <\/strong>Merchant Warehouse, <\/strong>21 Castle Street, <\/strong>Manchester. <\/strong><\/span><\/p>\n

Subject:\u00a0 Covid 19 P C R home test kits<\/b>
\n<\/span><\/td>\n<\/tr>\n

185<\/a><\/strong><\/span><\/td>\nTo: Privacy Transparency and Ethics Team, NHS Digital, 7 and 8 Wellington Place, Leeds<\/strong>
\nWest Yorkshire.<\/strong><\/span>Subject: Covid Pass for entry to place of work or social event<\/b><\/span><\/td>\n<\/tr>\n
184<\/a><\/strong><\/span><\/td>\nTo:\u00a0 LGFR.Consultations@gov.wales, Welsh Government, 5th Floor Ty Hywel, Cardiff Bay.<\/strong><\/span><\/p>\n

Subject:\u00a0 Regulatory Impact Assessment [R I A] for Rating [Wales] [Coronavirus] Regulations 2021<\/b><\/span><\/td>\n<\/tr>\n

183<\/a><\/strong><\/span><\/td>\nTo:\u00a0 J C V I Secretariat, Public health England, Wellington House, 133-155 Waterloo Road, London.<\/strong><\/span><\/p>\n

Subject:\u00a0 Covid 19 RT-PCR test data presented to J C V I <\/b>\u00a0<\/span><\/td>\n<\/tr>\n

182<\/a><\/strong><\/span><\/td>\nTo: Freedom of Information Officer, Information Rights Unit, Welsh Government, Cathays Park, <\/strong>Cardiff.<\/strong><\/span><\/p>\n

Subject: \u00a37.2 million gift of Personal Protective Equipment [P P E] from Wales to Namibia Africa <\/b>\u00a0<\/span><\/td>\n<\/tr>\n

181<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Gordon Ashworth, Director, Consumer Protection, Competition and Markets Authority [CMA], The Cabot, 25 Cabot Square, London. <\/strong><\/span><\/p>\n

Subject:\u00a0 \u00a0PCR Covid 19 Test Providers – harmful practices<\/b>
\n<\/span><\/td>\n<\/tr>\n

180<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, <\/strong>Department for Health and Social Care, <\/strong>39 Victoria Street, <\/strong>London. <\/strong><\/span><\/p>\n

Subject: Coronavirus [Covid 19] – Antibody testing<\/b><\/span><\/td>\n<\/tr>\n

179<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Customer Service Team, <\/strong>Customer Service Centre,\u00a0 <\/strong>Ceredigion County Council, <\/strong>Canolfan Rheidol, <\/strong>Llanbadarn Fawr, <\/strong>Aberystwyth. <\/strong><\/span><\/p>\n

Subject: \u00a0 <\/b>Covid 19 infection data provided to local media & “Gold Command” Status<\/b>
\n<\/b><\/span><\/td>\n<\/tr>\n

178<\/a><\/strong><\/span><\/td>\nTo:\u00a0 J C V I Secretariat, <\/strong>Public health England, <\/strong>Wellington House, <\/strong>133-155 Waterloo Road, <\/strong>London.<\/strong><\/span><\/p>\n

Subject: J C V I Annual Register of Members Interests<\/b><\/span><\/td>\n<\/tr>\n

177<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, Department for Health and Social Care, 39 Victoria Street, London.<\/strong><\/span><\/p>\n

Subject:\u00a0 Use of Graphene Oxide in water filtration<\/b><\/span><\/td>\n<\/tr>\n

176<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Officer, <\/strong>Information Rights Unit, <\/strong>Welsh Government,<\/strong>
\nCathays Park, <\/strong>Cardiff<\/strong><\/span><\/span>Subject:\u00a0 Covid 19 risk assessments by hospitality industry in Wales – effective from 7 August 2021. <\/b><\/span><\/span><\/td>\n<\/tr>\n
175<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Officer, <\/strong>Information Rights Unit, <\/strong>Welsh Government, <\/strong>Cathays Park, <\/strong>Cardiff.<\/strong><\/span><\/p>\n

Subject:\u00a0 Covid 19 Alert Level 0 Wales – FAQ updated 6 August 2021<\/b><\/span><\/td>\n<\/tr>\n

174<\/a><\/strong><\/span><\/td>\nTo:\u00a0 St George’s University Hospital, NHS Foundation Trust.<\/strong><\/span><\/p>\n

Subject:\u00a0 Covid 19 Vaccines in Pregnancy [Preg-CoV] Trial- IRAS No. 30115<\/b><\/span><\/td>\n<\/tr>\n

173c<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Dr June Raine, Chief Executive, Medicines and Healthcare Products Regulatory Agency [M H R A], 10 South Colonnade, Canary Wharf, London. <\/strong><\/span><\/p>\n

Subject: Concerns regarding the reported use of Graphene Oxide in experimental Covid 19 mRNA gene-editing therapies [vaccines]<\/b><\/span><\/td>\n<\/tr>\n

173b<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Dr June Raine, ,Chief Executive, Medicines and Healthcare Products Regulatory Agency,\u00a0 [M H R A], 10 South Colonnade, Canary Wharf, London.<\/strong><\/span><\/p>\n

Subject:\u00a0 Concerns regarding the reported use of Graphene Oxide in experimental Covid 19 mRNA gene-editing therapies [vaccines]<\/b><\/span><\/td>\n<\/tr>\n

173<\/a><\/strong>
\n<\/strong><\/span><\/td>\n		To:\u00a0Dr June Raine, Chief Executive, Medicines and Healthcare Products Regulatory Agency [M H R A], 10 South Colonnade, Canary Wharf, London<\/strong><\/span><\/p>\n

Subject:\u00a0Concerns regarding the reported use of Graphene Oxide in experimental Covid 19 mRNA gene-editing therapies [vaccines]<\/b><\/span><\/p>\n

 <\/td>\n<\/tr>\n

172<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, <\/strong>N H S – Wales.<\/strong><\/span><\/p>\n

Subject:\u00a0 Established Process for obtaining informed consent for vaccinations<\/b><\/span><\/td>\n<\/tr>\n

171<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, <\/strong>Department for Health and Social Care, <\/strong>39 Victoria Street, <\/strong>London.<\/strong><\/span><\/p>\n

Subject:\u00a0 \u00a0Pfizer Vaccine roll-out – Vulnerable children aged 12 to 17<\/b><\/span><\/td>\n<\/tr>\n

170<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Correspondence Team, Cabinet Office, 70 Whitehall, London.<\/span><\/p>\n

Subject: Covid 19 daily testing to avoid the need to self-isolate<\/b><\/span><\/td>\n<\/tr>\n

169<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Rt Hon Mark Drakeford MS, <\/strong>First Minister, <\/strong>Welsh Government, <\/strong>5th Floor Ty Hywel,\u00a0<\/strong>
\nCardiff Bay. <\/strong><\/span>Subject: Invalidity of RT-PCR testing process in Wales<\/b><\/span><\/td>\n<\/tr>\n
168<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Correspondence Team, <\/strong>Cabinet Office, <\/strong>70 Whitehall, <\/strong>London.<\/strong><\/span><\/p>\n

Subject: Confirmation that Health Secretary has tested positive for Covid 19<\/b><\/span><\/td>\n<\/tr>\n

167<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Director General and Editor in Chief, <\/strong>BBC Broadcasting House, <\/strong>Portland Place, <\/strong>London.<\/strong>
\nSubject: Covid 19 – Misleading information provided by BBC 16 July 2021<\/b><\/span><\/td>\n<\/tr>\n
166<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, <\/strong>Department for Health and Social Care, <\/strong>39 Victoria Street, <\/strong>London.<\/strong><\/span><\/p>\n

Subject:\u00a0 Health and Social Care Act 2008 – Statutory Instrument [Regulated Activities]<\/b><\/span><\/td>\n<\/tr>\n

165<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Customer Services Team, Medicines and Healthcare Products Regulatory Agency [M H R A], 10 South Colonnade, Canary Wharf, London.<\/strong><\/span><\/p>\n

Subject: V-Safe Covid 19 Vaccine Pregnancy Register<\/b><\/span><\/td>\n<\/tr>\n

164<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Rt Hon Mark Drakeford MS, First Minister, Welsh Government, 5th Floor Ty Hywel, Cardiff Bay.<\/strong><\/span><\/p>\n

Subject:\u00a0 Covid 19 gene-editing therapies [vaccines] – Informed Consent<\/b>
\n<\/span><\/td>\n<\/tr>\n

163<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Health and Social Services Committee, <\/strong>House of Commons, <\/strong>London. <\/strong><\/span><\/p>\n

Subject: Covid 19 – The Science behind the RT-PCR test<\/b><\/span><\/td>\n<\/tr>\n

162<\/a><\/strong><\/span><\/td>\nTo: Freedom of Information Team, NHS Wales. <\/strong><\/span><\/p>\n

Subject: NHS Wales External Whistleblowing Policy<\/b><\/span><\/td>\n<\/tr>\n

161<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Health and Social Care Committee, Welsh Parliament, Cardiff Bay. <\/strong><\/span><\/p>\n

Subject: Covid 19 – The Science behind the RT-PCR test<\/b><\/span><\/td>\n<\/tr>\n

160<\/a><\/strong><\/span><\/td>\nOpen letter to: Director General and Editor in Chief, BBC Broadcasting House, Portland Place, London. <\/strong><\/span><\/p>\n

Subject: BBC New – Coronavirus “Case” Numbers<\/b><\/span><\/td>\n<\/tr>\n

159<\/a><\/strong><\/span><\/td>\nOpen letter to:\u00a0 Rt Hon Eluned Morgan MS, Minister for Health and Social Services, Welsh Government, 5th Floor Ty Hywel, Cardiff Bay.<\/strong><\/span><\/p>\n

Subject: Covid 19 Vaccination roll-out in Wales<\/b><\/span><\/td>\n<\/tr>\n

158<\/a><\/strong><\/span><\/td>\nOpen letter to:\u00a0 Eifion Evans, Chief Executive Officer, Ceredigion County Council, Canolfan Rheidol, Llanbadarn Fawr, Aberystwyth.<\/strong><\/span><\/p>\n

Subject: Covid Safe Zones at Cardigan and Aberaeron<\/b><\/span><\/td>\n<\/tr>\n

157<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, Cabinet Office, 70 Whitehall, London.<\/strong><\/span><\/p>\n

Subject: The Influence of the Pharmaceutical Industry<\/b><\/span><\/td>\n<\/tr>\n

156<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, Department for Health and Social Care, 39 Victoria Street, <\/strong>London. <\/strong><\/span><\/p>\n

Subject: Genomic Sequencing data harvested from Covid 19 RT-PCR test results<\/b><\/span><\/td>\n<\/tr>\n

155<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Customer Service Team, Customer Service Centre, Ceredigion County Council, Canolfan Rheidol, Llanbadarn Fawr, Aberystwyth.<\/strong><\/span><\/p>\n

Subject: Modifications to public highway and foot-way Pendre Cardigan<\/b><\/span><\/td>\n<\/tr>\n

154<\/a><\/strong><\/span><\/td>\nTo: Customer Service Team, Customer Service Centre, Ceredigion County Council, Canolfan Rheidol, Llanbadarn Fawr, Aberystwyth.<\/strong><\/span><\/p>\n

Subject: Modifications to public highway layout at Cardigan Town<\/b>
\n<\/span><\/td>\n<\/tr>\n

153<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, Information Rights Unit, Welsh Government, Cathays Park, Cardiff. <\/strong><\/span><\/p>\n

Subject: Covid 19 Ferret Register Wales<\/b><\/span><\/td>\n<\/tr>\n

152<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Customer Contact Team, COG-UK Consortium, Addenbrooks Hospital, Hills Road, Cambridgeshire.\u00a0<\/strong><\/span><\/p>\n

Subject: COG-UK – Role of Covid 19 RT-PCR test in genome sequencing process<\/b><\/span><\/td>\n<\/tr>\n

151<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Health and Social Care Committee, <\/strong>House of Commons, <\/strong>London.<\/strong><\/span><\/p>\n

Subject:\u00a0 \u00a0Health Committee Report entitled “The influence of the Pharmaceutical Industry” <\/b><\/span><\/td>\n<\/tr>\n

150<\/a><\/strong><\/span><\/td>\nTo: Dr June Raine, <\/strong><\/span>Chief Executive, <\/strong><\/span>Medicines and Healthcare Products Regulatory Agency [MHRA], <\/strong><\/span>10 South Colonnade, <\/strong><\/span>Canary Wharf, <\/strong><\/span>London<\/strong><\/span><\/p>\n

Subject: Covid 19 Janssen Vaccine –\u00a0 Marketing Authorisation No. P L G B 00242\/0742 – Concerns regarding premature emergency authorisation for use in the human population<\/strong><\/span><\/td>\n<\/tr>\n

149<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, <\/strong>Medicines and Healthcare Products Regulatory, Agency [M H R A], <\/strong>10 South Colonnade, <\/strong>Canary Wharf, <\/strong>London. <\/strong><\/span><\/p>\n

Subject: Covid 19 Pfizer \/ BioNTech gene-editing treatment [vaccine] – Emergency authorisation for use in children [12 – 15 years of age].<\/b><\/span><\/td>\n<\/tr>\n

148<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, <\/strong>Information Service, <\/strong>National Health Service, [NHS] Wales.<\/strong><\/span><\/p>\n

Subject: Covid 19 vaccination programme – Wales. Request for information. – Spike protein mRNA vaccine. <\/b><\/span><\/td>\n<\/tr>\n

147<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Rt Hon Eluned Morgan MS, Minister for Health and Social Services, Welsh Government, 5th Floor, Ty Hywel, Cardiff Bay. <\/strong><\/span><\/p>\n

Subject: Covid 19 – Additional \u00a332 Million allocated in Wales for contact tracing based on RT-PCR test results – Request for review<\/b><\/span><\/td>\n<\/tr>\n

146<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Rt Hon Eluned Morgan MS, Minister for Health and Social Services, Welsh Government, <\/strong>5th Floor, Ty Hywel, Cardiff Bay, CF99 1NA<\/strong><\/span><\/p>\n

Subject: Covid 19 Certificate of Vaccination [Vaccine Passport] – Wales<\/b><\/span><\/td>\n<\/tr>\n

145<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Customer Contact Team, Medicines and Healthcare Products Regulatory Agency [M H R A], 10 South Colonnade, Canary Wharf, London.<\/strong><\/span><\/p>\n

Subject: \u00a0 Covid 19 Johnson & Johnson single dose vaccine<\/b><\/span><\/td>\n<\/tr>\n

144<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Correspondence Team, Cabinet Office, 70 Whitehall, London<\/strong><\/span><\/p>\n

Subject: Doctors for Covid Ethics – Paper dated 20 April 2021<\/b>
\n<\/span><\/td>\n<\/tr>\n

143<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Director General and Editor in Chief, BBC Broadcasting House, Portland Place, London.<\/strong><\/span><\/p>\n

Subject: Tragic death following vaccination<\/b><\/span><\/td>\n<\/tr>\n

142<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, Public Health England, Wellington House, 133-155 Waterloo Road, London<\/strong><\/span><\/p>\n

Subject: National Immunisation Management System [N I M S]<\/b><\/span><\/td>\n<\/tr>\n

141<\/a><\/strong><\/span><\/td>\nTo:\u00a0\u00a0Open letter to:\u00a0Director General and Editor in Chief, BBC Broadcasting House, Portland Place, London.<\/strong><\/span><\/p>\n

Subject: Journalistic Integrity at the BBC<\/strong><\/span><\/td>\n<\/tr>\n

140<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, <\/strong>Department for Health and Social Care, <\/strong>39 Victoria Street, <\/strong>London<\/strong><\/span><\/p>\n

Subject: Covid 19 – Sewage monitoring to provide early warning of coronavirus outbreak<\/b>
\n<\/span><\/td>\n<\/tr>\n

139<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, Medicines and Healthcare Products Regulatory Agency [M H R A], 10 South Colonnade, Canary Wharf, London.<\/strong><\/span><\/p>\n

Subject:\u00a0 “Cov-Boost Study” to evaluate Covid 19 vaccine boosters<\/b><\/span><\/td>\n<\/tr>\n

138<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Dr June Raine, Chief Executive, Medicines and Healthcare Products Regulatory Agency [M H R A],\u00a0<\/strong><\/span>10 South Colonnade, Canary Wharf, London.<\/span><\/strong><\/p>\n

Subject:\u00a0 Covid 19 Adverse drug reactions to experimental mRNA \/ DNA based gene-editing treatments<\/b>
\n<\/span><\/td>\n<\/tr>\n

137<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Rt Hon Mark Drakeford MS, First Minister, Welsh Government, 5th Floor Ty Hywel, Cardiff Bay.\u00a0<\/strong><\/span><\/p>\n

Subject: Validity of Covid 19\u00a0 RT-PCR test – external peer review by 22 international virologists, microbiologists and related scientists.<\/b><\/span><\/td>\n<\/tr>\n

136<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Dr June Raine, Chief Executive, Medicines and Healthcare Products Regulatory Agency [M H R A], 10 South Colonnade, Canary Wharf, London.<\/strong><\/span><\/p>\n

Subject: Covid 19 Adverse reactions to experimental gene-editing treatments – Quality of information<\/b><\/span><\/td>\n<\/tr>\n

135<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Correspondence Team, Cabinet Office, 70 Whitehall, London.<\/strong><\/span><\/p>\n

Subject: Serious Adverse Reactions to experimental Covid 19 gene-editing treatments: Financial Compensation Scheme<\/b><\/span><\/td>\n<\/tr>\n

134<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, <\/strong>Department for Health and Social Care [DHSC], <\/strong>39 Victoria Street, <\/strong>London.<\/strong><\/span><\/p>\n

Subject: 60 million Pfizer doses on order for booster vaccines in Autumn 2021<\/b><\/span><\/td>\n<\/tr>\n

133<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Dr June Raine, Chief Executive, Medicines and Healthcare Products Regulatory Agency [MHRA], 10 South Colonnade, Canary Wharf, London<\/strong><\/span><\/p>\n

Subject:\u00a0 \u00a0Oxford Covid 19 vaccine study in children [COV 006 Study] – Request for suspension \/ termination <\/b><\/span><\/td>\n<\/tr>\n

132<\/a><\/strong><\/span><\/td>\nTo: Customer Contact Centre, Office for National Statistics [O N S], Room D625, Government Buildings, Cardiff Road, Newport, South Wales.<\/strong><\/span><\/p>\n

Subject: Synchronisation of data recorded by O N S and M H R A<\/b><\/span><\/td>\n<\/tr>\n

131<\/a><\/strong><\/span><\/td>\nTo: Rt Hon Vaughan Gethin MS, Minister for Health and Social Services, Welsh Government, 5th Floor, Ty Hywel, Cardiff Bay.<\/strong><\/span><\/p>\n

Subject: Covid 19 Moderna vaccine roll-out in Wales<\/b><\/span><\/td>\n<\/tr>\n

130<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Customer Services Team, <\/strong>Medicines and Healthcare Products Regulatory Agency [M H R A], <\/strong>10 South Colonnade, <\/strong>Canary Wharf, <\/strong>London.<\/strong><\/span><\/p>\n

Subject: Role of M H R A as independent medical regulator<\/b><\/span><\/td>\n<\/tr>\n

129<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, Medicines and Healthcare Products Regulatory Agency [M H R A], 10 South Colonnade, Canary Wharf, London.<\/strong>
\nSubject: Covid 19 Vaccines – Risk v Benefit analysis<\/b><\/span><\/td>\n<\/tr>\n
128<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, Department for Health and Social Care, 39 Victoria Street, <\/strong>London.<\/strong><\/span><\/p>\n

Subject: Panorama Undercover Investigation – Covid testing laboratory<\/b><\/span><\/td>\n<\/tr>\n

127<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Correspondence Team, Cabinet Office, 70 Whitehall, London.<\/strong><\/span><\/p>\n

Subject: Coronavirus Crisis – Conflicts of Interest<\/b><\/span><\/td>\n<\/tr>\n

126<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Correspondence Team, Cabinet Office, 70 Whitehall, London.<\/strong><\/span><\/p>\n

Subject:\u00a0 Covid 19 national vaccination programme – Accountability for national roll-out decision<\/b><\/span><\/td>\n<\/tr>\n

125<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Correspondence Team, Cabinet Office, 70 Whitehall, London.<\/strong><\/span><\/p>\n

Subject: \u00a0Covid 19 vaccines: Adverse Reaction Reports from M H R A<\/b><\/span><\/td>\n<\/tr>\n

124<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Customer Contact Team, Medicines and Healthcare Products Regulatory Agency [M H R A], 10 South Colonnade, Canary Wharf, London.\u00a0<\/strong><\/span><\/p>\n

Subject: General Vaccine Approval Process<\/b>
\n<\/span><\/td>\n<\/tr>\n

123<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Rt Hon Meg Hillier MP, Chair – Public Accounts Committee, House of Commons, London. <\/strong><\/span><\/p>\n

Subject: Public Accounts Committee Report – Concerns regarding \u00a337 billion budget for Test and Trace Programme <\/b><\/span><\/td>\n<\/tr>\n

122<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Medicines and Healthcare Products Regulatory Agency [M H R A],\u00a0<\/strong><\/span>10 South Colonnade, <\/span>Canary Wharf, <\/span>London.<\/span><\/strong><\/p>\n

Subject: R T – P C R test for Covid 19 diagnosis.<\/strong><\/span><\/td>\n<\/tr>\n

121<\/a><\/strong><\/span><\/td>\n\n

To:\u00a0 Customer Contact Centre, Office for National Statistics, Room D625, Government Buildings, <\/strong>Cardiff Road, Newport, South Wales.<\/strong><\/span><\/span><\/p>\n

Subject: Covid 19 vaccination programme – Adverse Reaction Reports from MHRA<\/b><\/span><\/span><\/p>\n<\/td>\n<\/tr>\n

120<\/a><\/strong><\/span><\/td>\n\n

To:\u00a0 Rt Hon Mark Drakeford MS, First Minister, Welsh Government, 5th Floor Ty Hywel, Cardiff Bay. <\/strong><\/span><\/span><\/p>\n

Subject: Covid 19 RT-PCR Amplification Cycle Threshold [C t] – Economic lockdown Wales<\/b><\/span><\/span><\/p>\n<\/td>\n<\/tr>\n

119<\/a><\/strong><\/span><\/td>\n\n

To:\u00a0 Correspondence Team, Cabinet Office, 70 Whitehall, London.<\/strong><\/span><\/span><\/p>\n

Subject: Coronavirus Crisis – Independent Public Inquiry<\/b><\/span><\/span><\/p>\n<\/td>\n<\/tr>\n

118<\/a><\/strong><\/span><\/td>\n\n

To:\u00a0 Freedom of Information Team, Department for Health and Social Care, 39 Victoria Street, London.<\/strong><\/span><\/span><\/p>\n

Subject: Coronavirus-related contracts – Unlawful Action<\/b><\/span><\/span><\/p>\n<\/td>\n<\/tr>\n

117<\/a><\/strong><\/span><\/td>\n\n

To:\u00a0 Correspondence Team, Cabinet Office, 70 Whitehall, London.<\/strong>
\nSubject: Covid 19 – Vaccine Passports<\/b><\/span><\/span><\/p>\n<\/td>\n<\/tr>\n

116<\/a><\/strong><\/span><\/td>\n\n

To:\u00a0 Correspondence Team, <\/strong><\/span>Cabinet Office, <\/span><\/strong>70 Whitehall. <\/span><\/strong>London.<\/span><\/strong><\/span><\/p>\n

Subject:\u00a0 Covid 19 National Vaccine Advertising Campaign – Stage 1 Complaint<\/b><\/span><\/p>\n<\/td>\n<\/tr>\n

115<\/a><\/strong><\/span><\/td>\n\n

To:\u00a0 Freedom of Information Team, <\/strong><\/span>National Health Service, <\/span>NHS England.<\/span><\/strong><\/span><\/p>\n

Subject: Covid 19 – National Vaccine advertising campaign<\/b><\/span><\/p>\n<\/td>\n<\/tr>\n

114<\/a><\/strong><\/span><\/td>\nTo:\u00a0 Freedom of Information Team, Public Health England [P H E], Wellington House, 133-155 Waterloo Road’ London.<\/strong><\/span><\/span><\/p>\n

Subject: Covid 19 Re-calibration of RT-PCR test to detect virus variant VOC202012\/02 [South African variant]<\/b><\/span><\/span><\/td>\n<\/tr>\n

113<\/a><\/strong><\/span><\/td>\nTo: Freedom of Information Team, <\/strong>Cabinet Office, <\/strong>70 Whitehall, <\/strong>London<\/strong><\/span><\/span><\/p>\n

Subject: Covid 19 – Mass testing programme for SARS-CoV-2 virus<\/b><\/span><\/span><\/td>\n<\/tr>\n

112<\/a><\/strong><\/span><\/td>\nTo: Freedom of Information Team, Department for Health and Social Care, 39 Victoria Street, London<\/strong><\/span><\/span><\/p>\n

Subject: Oxford Covid 19 vaccine study in children [COV 006 Study]<\/b><\/span><\/span><\/td>\n<\/tr>\n

111<\/a><\/strong><\/span><\/td>\nTo: Freedom of Information Team, Medicines and Healthcare Products Regulatory Agency [M H R A]. 10 South Colonnade, Canary Wharf, London.<\/strong><\/span><\/span><\/p>\n

Subject: Yellow Card Reporting<\/b><\/span><\/td>\n<\/tr>\n

110<\/a><\/strong><\/span><\/td>\nTo: Freedom of Information Team; Office for National Statistics,\u00a0 Government Buildings, Cardiff Road, <\/strong><\/span>Newport.<\/span><\/strong><\/span><\/p>\n

Subject: Covid 19 Vaccination Programme – Post-vaccination deaths<\/b><\/span><\/td>\n<\/tr>\n

109<\/a><\/strong><\/span><\/td>\nTo: SAGE Group<\/b><\/span><\/p>\n

Subject:\u00a0Covid 19 – SARS-CoV-2: New variant identified at Bristol and Liverpool<\/b><\/span><\/td>\n<\/tr>\n

108<\/a><\/strong><\/span><\/td>\nOpen letter to: Correspondence Team, Cabinet Office, 70 Whitehall, London. SW1A 2AS<\/strong><\/span><\/p>\n

Subject: Covid 19 Vaccination Programme – Nuremberg Code<\/b><\/span><\/td>\n<\/tr>\n

107<\/span><\/span><\/a><\/strong><\/span><\/td>\nTo: SAGE Group<\/strong>
\n<\/b><\/span>Subject: Covid 19 – SARS-CoV-2: New variant from South Africa<\/b><\/span><\/td>\n<\/tr>\n
106<\/span><\/span><\/a>
\n<\/span><\/span><\/strong><\/span><\/td>\n		\n

To: Dr June Raine, Chief Executive Medicines and Healthcare Products Regulatory Agency [M H R A]<\/strong>
\n<\/span><\/span><\/p>\n

Subject: Covid 19 Vaccines – Adverse Drug Reaction [A D R]<\/b><\/span><\/td>\n<\/tr>\n

105<\/a>\u00a0\u00a0<\/strong><\/span><\/td>\n\n

To: Correspondence Team, <\/strong><\/span>Cabinet Office, <\/span>70 Whitehall. <\/span>London<\/span><\/strong><\/span><\/p>\n

Subject: Validity of Covid 19 RT-PCR test and Lateral Flow test<\/b><\/span><\/p>\n<\/td>\n<\/tr>\n

104<\/a>\u00a0<\/strong><\/span><\/td>\n\n

To: Freedom of Information Officer, <\/strong><\/span>Information Rights Unit, <\/span><\/strong>Welsh Government.<\/span><\/strong><\/span><\/p>\n

Subject: C J \/ 104: \u00a0 \u00a0 Covid 19 – Significant Scientific Evidence of spread within supermarkets<\/strong><\/span><\/p>\n<\/td>\n<\/tr>\n

103<\/a>\u00a0<\/strong><\/span><\/td>\n\n

To: Correspondence Team, <\/strong><\/span>Cabinet Office, <\/span><\/strong>70 Whitehall, <\/span><\/strong>London<\/span><\/strong>\u00a0<\/span><\/span><\/p>\n

Subject:\u00a0 C J\/103:\u00a0\u00a0 Pfizer BioNTech Vaccine – Adverse Reaction Reports<\/b><\/span><\/p>\n<\/td>\n<\/tr>\n

102<\/a><\/strong><\/span><\/td>\n\n

To: Correspondence Team, <\/strong><\/span>Cabinet Office, <\/span>70 Whitehall.<\/span><\/strong><\/span><\/p>\n

Subject: Covid 19 – External Investigation<\/b><\/span><\/span><\/p>\n<\/td>\n<\/tr>\n

101<\/a><\/strong><\/span><\/td>\n\n

To: Chief Executive, Medicines and Healthcare Products Regulatory Agency [M H R A].\u00a0<\/strong><\/span><\/p>\n

Subject: Pfizer \/ BioNTech vaccine – R.174 Human Medicines Regulations [H M R] 2012<\/b><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

<\/div>\n
\n

101 Enquiry<\/b><\/span><\/h4>\n

Dr June Raine<\/span>
\nChief Executive<\/span>
\nMedicines and Healthcare Products Regulatory Agency [M H R A]<\/span>
\n10 South Colonnade<\/span>
\nCanary Wharf<\/span>
\nLondon<\/span>
\nE14 4PU<\/span><\/p>\n

Date: 14\u00a0 12\u00a0 2020<\/span><\/p>\n

Dear Dr Raine<\/span><\/p>\n

Subject: Pfizer \/ BioNTech vaccine – R.174 Human Medicines Regulations [H M R] 2012<\/b><\/span><\/p>\n

I refer to the above subject and attach the following documentation.<\/span><\/p>\n

    \n
  1. 174R\u00a0H M R 2012 – original version [<\/span>LINK<\/span><\/span><\/a>]<\/span><\/span><\/li>\n
  2. R.174 H M R 2012 – updated version [<\/span>LINK<\/span><\/span><\/a>]<\/span><\/span><\/li>\n<\/ol>\n

    I note adverse reactions as outlined in Section 2 [highlighted] of your updated version. In view of the adverse reactions to this vaccine can you please ensure that future updates to the document are dated, to ensure amendments to the document can be tracked. You confirm that no data is available in individuals with weakened immune systems. Does M H R A therefore consider there is a risk to those over 80 years of age as this age group is likely to have weakened immune system, particularly following the Government’s shielding policy when they were denied access to sunlight and vitamin D to boost their immune system. You also appear to have identified a risk to those using other medication or have recently received any other vaccine. Does this include vaccine for seasonal influenza. You further advise that side effects may temporarily affect the ability to drive or use machines. Can you please arrange to publish your findings on your website so that the general public can take informed decisions on the risks involved.\u00a0 <\/span><\/p>\n

    Given that mRNA vaccines have not previously been administered to the human population, with animal testing still ongoing to establish the impact on fertility, please advise what process has been established by M H R A to monitor adverse reactions in the short, medium and long term. <\/span><\/p>\n

    A prompt reply would be appreciated as this vaccine is now being administered to the elderly with weakened immune systems. Thank you.\u00a0 \u00a0 \u00a0 <\/span>
    \n\u00a0<\/span>
    \nYours sincerely<\/span><\/p>\n

    Wynne Jones<\/span><\/p>\n

    (BGB Correspondence Journal Editor)<\/em><\/span><\/p>\n

    Stakeholders [for information]<\/b><\/span>
    \nCabinet Office UK Government<\/span>
    \nFirst Minister Wales – Rt Hon Mark Drakeford MS<\/span><\/p>\n

    \n

    101 Response<\/strong><\/span><\/p>\n\n\n\n\n\n\n\n
    Subject:<\/span><\/th>\nFW: CSC 24709 – Pfizer \/ BioNTech vaccine – R.174 Human Medicines Regulations [H M R] 2012<\/span><\/td>\n<\/tr>\n
    Date:<\/span><\/th>\nWed, 16 Dec 2020 16:10:38 +0000<\/span><\/td>\n<\/tr>\n
    From:<\/span><\/th>\nNews Centre <newscentre@mhra.gov.uk><\/a><\/span><\/td>\n<\/tr>\n
    To:<\/span><\/th>\ncj-editor@biggeesblog.cymru<\/a> <cj-editor@biggeesblog.cymru><\/a><\/span><\/td>\n<\/tr>\n
    CC:<\/span><\/th>\nNews Centre <newscentre@mhra.gov.uk><\/a><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    Hi Wynne,<\/span><\/p>\n

    Thank you for your email.<\/span><\/p>\n

    Please find our response to your enquiry below.<\/span><\/p>\n

    As with any vaccine or medicine, COVID-19 vaccines require continuous safety monitoring and this ensures that the benefits in protecting people against COVID-19 outweigh any side effects or potential risks. We have in place a robust and proactive safety monitoring strategy for COVID-19 vaccines which allows for near real-time safety monitoring at population level. The fact that these incidents were picked up quickly show that to be the case.<\/span><\/p>\n

    A primary responsibility of the MHRA is the protection of public safety through the effective monitoring of all medicines and healthcare products, including the vaccines that we have approved in the fight against COVID-19. This is a process known as safety monitoring (pharmacovigilance). This allows any new risks to be identified and measures can be taken to support safe and effective use.\u00a0<\/span><\/p>\n

    Building on our existing system for monitoring the use of medicines and medical devices, we have expanded our Yellow Card reporting system by creating a dedicated website for COVID-19 vaccine side effect reporting.<\/span><\/p>\n

    We also have regular interaction with the vaccine manufacturers in relation to emerging safety data.<\/span><\/p>\n

    Please note, we published the Public Assessment Report (PAR) for the Pfizer\/BioNTech vaccine here where you can find out more information:<\/span><\/p>\n

    https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/944544\/COVID-19_mRNA_Vaccine_BNT162b2__UKPAR___PFIZER_BIONTECH__15Dec2020.pdf<\/a><\/span><\/p>\n

    I hope this helps.<\/span><\/p>\n

    Thanks<\/span><\/p>\n

    Tafi Maruta <\/strong><\/span><\/p>\n

    News and Digital Specialist <\/span>
    \nCommunications Division – News & Digital Content<\/span><\/p>\n

    Medicines and Healthcare products Regulatory Agency<\/strong><\/span>
    \n10 South Colonnade, Canary Wharf, London E14 4PU<\/span><\/p>\n

    Direct line:<\/strong> 020 3080 6978<\/span><\/p>\n

    \n

    102 Enquiry<\/b><\/span><\/h4>\n

    Correspondence Team<\/span>
    \nCabinet Office<\/span>
    \n70 Whitehall <\/span>
    \nLondon<\/span>
    \nSW1A 2AS<\/span><\/p>\n

    Date: 20\u00a0 12\u00a0 2020<\/span><\/p>\n

    Dear Correspondence Team<\/span><\/p>\n

    Subject: Covid 19 – External Investigation<\/b><\/span><\/p>\n

    An external investigation into the management of the Covid 19 crisis remains ongoing with extended terms of reference. To inform the investigation, I would be pleased to receive your response to the concerns set out below under the respective sub-headings<\/span><\/p>\n

    R T – P C R test<\/b><\/span>
    \nI attach external peer review of the RT-PCR test<\/span> [    LINK<\/span><\/a><\/span>]. You will note that 10 major scientific flaws at the molecular and methodological level have been identified with the review authors concluding that the test cannot be used as a diagnostic for SARS viruses. This is reinforced by test kit manufacturers: clear warning notices are included with every kit confirming the test should not be used for diagnosis of viral infections. The Portuguese appeal court on 11 November 2020 came to a similar conclusion. A summary of their findings is also attached<\/span> [LINK<\/span><\/span><\/a>]. It would therefore appear that totally misleading data in terms of daily “case” numbers has been presented to government ministers with that flawed data used to inform economic lock down strategy \/ policy. The general public will also have received misleading statistics in daily BBC new bulletins. The Health Data Team at “Office for National Statistics” will now need to reevaluate the data provided during the first and second wave of this crisis taking into consideration the flawed test results. This evidence will need to be presented to the forthcoming “Independent Public Inquiry” into the management of the crisis as there are wide-ranging social<\/i>, economic <\/i>and healthcare <\/i>implications. I take the view that the ministerial decision, announced 18 December, to mass test school children in England early in the new year should be revoked to avoid further misuse of public funds. The Public Inquiry chair should be appointed by the Prime Minister without further delay and provided with a clear brief [scrutinised by MP’s] to investigate the flawed test issue in detail. Additionally, an internal investigation by the “Cabinet Office” should be undertaken with “cost v benefit analysis” presented to Members of Parliament. This should be supplemented with an external investigation by the “National Audit Office”\u00a0 to establish why the economy of the UK has been locked down [with serious impacts on healthcare and livelihoods] on the basis of completely flawed test results from a test that can not be used to diagnose viral infection. There are likely to be national, regional and even global implications as the RT-PCR test is used in various countries around the world. The involvement of the World Heath Organisation [with their close links to major pharmaceutical companies] should be scrutinised in detail in any future investigation to establish why this pseudo-science has been allowed to prevail. \u00a0 \u00a0 <\/span><\/span><\/p>\n

    Pfizer \/ BioNTech Vaccine – BNT162b2<\/b><\/span>
    \nHaving now examined the Public Assessment Report [PAR]<\/i> published by the “Medicines and Healthcare Products Regulatory Agency [M H R A]” I attach a document setting out a summary of their findings, together with supplementary information<\/span> [    LINK<\/span><\/a><\/span>]. It is a matter of concern to various eminent members of the medical and scientific profession [as listed in the document] that this experimental mRNA vaccine has received temporary authorisation for use in the human population by the M H R A following a request from UK Government under R.174 of Human Medicines Regulations 2012. Those that have now received the vaccine are an extension to the study programme. The PAR clearly confirms that a fertility and developmental study in rats is currently ongoing with the M H R A unable to confirm what the impact of genetic changes to human DNA brought about by this new-generation gene-editing vaccine will be. The impact on pregnant women is not known. It remains unclear whether the genetic modifications can be passed from parent to offspring and thus impact future generations in perpetuity. You will note that no genotoxicity<\/i> studies have been undertaken and no such studies are planned. Those with weakened immune systems are now advised by M H R A not to take the vaccine. It remains unclear therefore why it is being administered to the elderly: those over 80 years of age that are likely to have weakened immune systems, particularly following the governments’ shielding policy that deprived the elderly of sunlight and hence vitamin D: essential for boosting the immune system to protect against viral infection. Prolonged mask wearing also depletes the immune system and results in hypoxia<\/i> [lack of oxygen] and hypercapnia<\/i> [build up of carbon dioxide in the blood]. Given the serious concerns expressed by the medical and scientific profession, does UK Government intend to provide the general public with details of the risks <\/i>and benefits <\/i>to ensure that informed decisions can be taken by the public prior to vaccination. Now that it has been established that the RT-PCR test should not be used as a diagnostic tool to detect viral infection with totally misleading information presented to ministers regarding daily “case” numbers, the rapid roll-out of the vaccine can not be justified on public health grounds, due to the major scientific flaws in the testing process. \u00a0 \u00a0 \u00a0 \u00a0 <\/span><\/span><\/p>\n

    The Great Reset<\/b><\/span>
    \nI would be grateful if you could confirm whether UK Government is committed to implementing the “Great Reset” as explained in detail on “World Economic Forum” website at this link:<\/span>     https:\/\/www.weforum.org\/great-reset\/<\/a><\/span><\/span>\u00a0 Is the “reset” to be achieved through implementation of United Nations Agenda 21 [now renamed Agenda 2030]: this being an agenda to transform the world through a plan of action to deliver sustainable development [economic, social and environmental] with all countries acting in collaborative partnerships to implement 17 sustainable development goals and 169 targets over a 15 year period ending 2030. The action plan requires governments and public institutions to work closely on implementation with regional and local authorities, sub-regional institutions, international institutions, academia, philanthropic organisations, volunteer groups and others. Full details are available at this link:<\/span><\/span><\/p>\n

    \n

    https:\/\/www.un.org\/sustainabledevelopment\/development-agenda\/<\/a><\/span><\/span><\/p>\n

    I look forward to your reply at your earliest convenience. Thank you. <\/span><\/p>\n

    Yours sincerely<\/span><\/p>\n

    Wynne Jones<\/span><\/p>\n<\/div>\n

    (BGB Correspondence Journal Editor)<\/em><\/span><\/div>\n
    <\/div>\n

    Stakeholders [for information]<\/b><\/span>
    \nNational Audit Office<\/span><\/p>\n

    \n

    102 Response<\/strong><\/span><\/p>\n

    Awaiting reply<\/span><\/p>\n

    \n

    103 Enquiry<\/b><\/span><\/h4>\n

    Correspondence Team<\/span>
    \nCabinet Office<\/span>
    \n70 Whitehall<\/span>
    \nLondon<\/span>
    \nSW1A 2AS<\/span><\/p>\n

    Date: 14\u00a0 01\u00a0 2021<\/span><\/p>\n

    Dear Correspondence Team<\/span><\/p>\n

    Subject:\u00a0 C J\/103:\u00a0\u00a0 Pfizer BioNTech Vaccine – Adverse Reaction Reports<\/b><\/span><\/p>\n

    I refer to the above subject. Your attention is drawn to reports of adverse reactions [including deaths] following vaccination, as listed in Annex 01 below. Consequently, I would be grateful if you could urgently consider publishing, on UK Government website or “Medicines and Healthcare Products Regulatory Agency” [M H R A] website, a summary of\u00a0 “Adverse Reaction Reports<\/b>“. This will enable the general public to take informed <\/u>decisions on whether they wish to accept the vaccine. A prompt reply would be appreciated as the vaccine is currently being rolled-out in the UK.<\/span><\/p>\n

    It is important to note that Pfizer are on record as confirming that the vaccine does not decrease the risk of infection, but lowers the effects of symptoms. This begs the question, what is the purpose of the vaccine. Covid 19 symptoms are particularly mild or non-existent in the vast majority of infected people. This calls into question the logic of the current vaccine roll-out.<\/span><\/p>\n

    I look forward to your reply at your earliest convenience, following consultation with\u00a0 M H R A. Thank you.<\/span><\/p>\n

    Yours sincerely<\/span><\/p>\n

    Wynne Jones<\/span><\/p>\n

    (BGB Correspondence Journal Editor)<\/em><\/span><\/p>\n

    Annex 01<\/b><\/span>
    \nExperimental COVID Vaccines: Pfizer Vaccine Fallout<\/span><\/span>
    \nCDC data shows that 3,150 people are now\u00a0\u201cunable to perform normal daily activities, unable to work\u201d<\/em>\u00a0after vaccination. This is 2.7% of people who took it<\/span>
    \n    https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2020-12\/slides-12-19\/05-COVID-CLARK.pdf<\/a><\/span>
    \nPortuguese health worker, 41, dies two days after getting the Pfizer covid vaccine as her father says he \u201cwants answers\u201d<\/span>
    \n    https:\/\/trib.al\/eEWi66p<\/a><\/span>
    \nMexican doctor hospitalized after receiving COVID-19 vaccine<\/span>
    \n    https:\/\/www.reuters.com\/article\/health-coronavirus-mexico-vaccines-idUSKBN2970H3<\/a><\/span>
    \nHundreds of Israelis get infected with Covid-19 after receiving Pfizer\/BioNTech vaccine<\/span>
    \n    https:\/\/www.rt.com\/news\/511332-israel-vaccination-coronavirus-pfizer\/<\/a><\/span>
    \nWife of \u2018perfectly healthy\u2019 Miami doctor, 56, who died of a blood disorder 16 days after getting Pfizer Covid-19 vaccine is certain it was triggered by the jab, as drug giant investigates first death with a suspected link to shot<\/span>
    \n    https:\/\/www.dailymail.co.uk\/news\/article-9119431\/Miami-doctor-58-dies-three-weeks-receiving-Pfizer-Covid-19-vaccine.html<\/a><\/span>
    \n75-year-old Israeli man dies 2 hours after getting Covid-19 vaccine<\/span>
    \n    https:\/\/www.israelnationalnews.com\/News\/News.aspx\/293865<\/a><\/span>
    \nDeath of Swiss man after Pfizer vaccine<\/span>
    \n    https:\/\/www.reuters.com\/article\/us-health-coronavirus-swiss-death-idUSKBN29413Y<\/a><\/span>
    \n88-year-old collapses and dies several hours after being vaccinated<\/span>
    \n    https:\/\/www.israelnationalnews.com\/News\/News.aspx\/293952<\/a><\/span>
    \nThousands negatively affected after getting Covid-19 vaccine<\/span>
    \n    https:\/\/m.theepochtimes.com\/thousands-negatively-affected-after-getting-covid-19-vaccine_3625914.html<\/a><\/span>
    \nHospital worker with no prior allergies in intensive care with severe reaction after Pfizer Covid vaccine<\/span>
    \n    https:\/\/metro.co.uk\/2020\/12\/16\/hospital-worker-in-intensive-care-after-suffering-severe-allergic-reaction-to-covid-vaccine-13763695\/<\/a><\/span>
    \n4 volunteers develop FACIAL PARALYSIS after taking Pfizer Covid-19 jab, prompting FDA to recommend \u2018surveillance for cases\u2019<\/span>
    \n    https:\/\/www.rt.com\/usa\/509081-pfizer-vaccine-fda-bells-palsy-covid\/<\/a><\/span>
    \nInvestigation launched as 2 people die in Norway nursing home days after receiving Pfizer\u2019s Covid-19 vaccine<\/span>
    \n    https:\/\/www.rt.com\/news\/511623-norway-covid19-vaccine-deaths\/<\/a><\/span>
    \nHundreds Sent to Emergency Room After Getting COVID-19 Vaccines<\/span>
    \n    https:\/\/m.theepochtimes.com\/hundreds-sent-to-emergency-room-after-getting-covid-19-vaccines_3644148.html<\/a><\/span>
    \nUS officials report more severe allergic reactions to COVID-19 vaccines<\/span>
    \n    https:\/\/www.google.com\/amp\/s\/mobile.reuters.com\/article\/amp\/idUSKBN29B2GS<\/a><\/span>
    \nNHS told not to give COVID vaccine to those with history of allergic reactions<\/span>
    \n    https:\/\/www.google.com\/amp\/s\/amp.theguardian.com\/world\/2020\/dec\/09\/pfizer-covid-vaccine-nhs-extreme-allergy-sufferers-regulators-reaction<\/a><\/span>
    \nCOVID-19: Single vaccine dose leads to \u2018greater risk\u2019 from new coronavirus variants, South African experts warn<\/span>
    \n    news.sky.com\/story\/amp\/covid-19-single-vaccine-dose-leads-to-greater-risk-from-new-coronavirus-variants-south-african-experts-warn-12180837<\/a><\/span>
    \nCDC reveals at least 21 Americans have suffered life threatening allergic reactions to Pfizer\u2019s COVID vaccine<\/span>
    \n    www.dailymail.co.uk\/health\/article-9119029\/amp\/At-21-Americans-life-threatening-anaphylaxis-receiving-Pfizers-vaccine-CDC-reveals.html<\/a><\/span>
    \nWoman experiences side effects of COVID-19 vaccine<\/span>
    \n    www.everythinglubbock.com\/news\/local-news\/woman-experiences-side-effects-of-covid-19-vaccine\/amp\/<\/a><\/span>
    \nCOVID vaccine side effects more common after 2nd dose<\/span>
    \n    www.boston.cbslocal.com\/2021\/01\/05\/covid-vaccine-side-effects-fever-reaction\/amp\/<\/a><\/span>
    \nBulgaria reports 4 cases of side effects from Pfizer COVID vaccine<\/span>
    \n    www.ndtv.com\/world-news\/bulgaria-reports-4-cases-of-side-effects-from-pfizer-covid-vaccine-2347667%3famp=1&akamai-rum=off<\/a><\/span>
    \nTwo NHS workers suffer allergic reaction to Pfizer vaccine<\/span>
    \n    https:\/\/www.google.com\/amp\/s\/www.telegraph.co.uk\/global-health\/science-and-disease\/coronavirus-news-vaccine-pfizer-nhs-oxford-covid-uk-cases\/amp\/<\/a><\/span><\/p>\n

    \n

    103 Response<\/strong><\/span><\/p>\n

    Dear Wynne Jones,<\/span><\/p>\n

    Thank you for your email.<\/span><\/p>\n

    Please see our response to your enquiry below.<\/span><\/p>\n

    We are aware of recent articles published in the media in relation to deaths post vaccination. All reports of side effects from the UK vaccination campaign undergo robust scientific evaluation by the MHRA alongside data available from international sources. This is further considered by the Commission on Human Medicine and its Expert Advisory Groups.<\/span><\/p>\n

    Those at the highest risk of COVID 19 complications, whether due to their elderly age and\/or underlying chronic illnesses, are currently prioritised for vaccination. It is not unexpected that some of these people may naturally fall ill due to their age or underlying conditions shortly after being vaccinated, without the vaccine playing any role in that. We have robust surveillance systems in place to rapidly review all reports of suspected side effects to determine whether these are possible new risks, or coincidental medical events.<\/span><\/p>\n

    Vaccine safety\u202fis of paramount importance and we continually monitor the safety of vaccines to ensure that the benefits outweigh any potential risks. The MHRA encourages anyone to report any suspicion or concern they have beyond the known, mild side effects on the Coronavirus Yellow Card<\/a> site. Reporters do not need to be sure of a link between a vaccine and a suspected side effect but are still encouraged to report.<\/span><\/p>\n

    I hope you find this helpful. <\/span><\/p>\n

    Kind regards, <\/span>
    \nAmelia<\/span><\/p>\n

    \n

    104 Enquiry<\/b><\/span><\/h4>\n

    Freedom of Information Officer<\/span>
    \nInformation Rights Unit<\/span>
    \nWelsh Government<\/span>
    \nCathays Park<\/span>
    \nCardiff<\/span>
    \nCF10 3NQ<\/span><\/p>\n

    Date: 15\u00a0 01\u00a0 2021<\/span><\/p>\n

    Dear Freedom of Information Officer<\/span><\/p>\n

    Subject: C J \/ 104: \u00a0 \u00a0 Covid 19 – Significant Scientific Evidence of spread within supermarkets<\/strong><\/span><\/p>\n

    I refer to the above subject. Your attention is drawn to an abstract from BBC News dated 15 January, reproduced in Annex 01 below. I would be grateful if you could arrange to provide me with the following information under the F O I Act 2000 at your earliest convenience .<\/span><\/p>\n